Similarly, in hepatocellular carcinoma (HCC), the expression of PRMT1, -5, and -9 has been correlated with disease advancement, suggesting these as potential therapeutic targets (54, 55, 56). This evidence concerns the gene PRMT1 and hepatocellular carcinoma.